Αποτελέσματα αναζήτησης - David T. Dicker
- Εμφανίζονται 1 - 20 Αποτελέσματα από 37
- Μετάβαση στην Επόμενη Σελίδα
-
1
-
2
-
3
Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-... από Zhaoyu Jin, E. Robert McDonald, David T. Dicker, Wafik S. El‐Deiry
Έκδοση 2004Artigo -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases από Akshal Patel, Joshua E. Allen, David T. Dicker, Kristi L. Peters, Jonas M. Sheehan, Michael Glantz, Wafik S. El‐Deiry
Έκδοση 2011Artigo -
14
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway από Joshua E. Allen, Gabriel Krigsfeld, Luv Patel, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry
Έκδοση 2015Artigo -
15
Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation από Varun V. Prabhu, Bo Hong, Joshua E. Allen, Shengliang Zhang, Amriti R. Lulla, David T. Dicker, Wafik S. El‐Deiry
Έκδοση 2016Artigo -
16
-
17
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth, and chemosensitivity under hypoxic conditions από Elizabeth Matthew, Lori S. Hart, Aristotelis Astrinidis, Arunasalam Navaraj, Nathan G. Dolloff, David T. Dicker, Elizabeth P. Henske, Wafik S. El‐Deiry
Έκδοση 2009Artigo -
18
Death Induction by Recombinant Native TRAIL and Its Prevention by a Caspase 9 Inhibitor in Primary Human Esophageal Epithelial Cells από Seok‐Hyun Kim, Kunhong Kim, Jae Kwagh, David T. Dicker, Meenhard Herlyn, Anil K. Rustgi, Youhai Chen, Wafik S. El‐Deiry
Έκδοση 2004Artigo -
19
Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53 από Bo Hong, Varun V. Prabhu, Shengliang Zhang, A. Pieter J. van den Heuvel, David T. Dicker, Levy Kopelovich, Wafik S. El‐Deiry
Έκδοση 2013Artigo -
20
Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis από Junaid Abdulghani, Joshua E. Allen, David T. Dicker, Yingqiu Yvette Liu, David Goldenberg, Charles D. Smith, Robin Humphreys, Wafik S. El‐Deiry
Έκδοση 2013Artigo
Εργαλεία αναζήτησης:
Σχετικά θέματα
Cancer research
Biology
Biochemistry
Cancer
Medicine
Chemistry
Apoptosis
Cell biology
Internal medicine
Gene
Genetics
Pharmacology
Cell cycle
Colorectal cancer
Programmed cell death
Breast cancer
Cancer cell
Immunology
Kinase
Molecular biology
Oncology
Hepatocellular carcinoma
Sorafenib
Tumor necrosis factor alpha
Cell
Cell culture
Circulating tumor cell
Downregulation and upregulation
Metastasis
Metastatic breast cancer